Richard Hague

2018 - Anika Therapeutics

In 2018, Richard Hague earned a total compensation of $827.2K as Chief Commercial Officer at Anika Therapeutics, a 22% decrease compared to previous year.

Compensation breakdown

Bonus$105,779
Option Awards$363,305
Salary$335,806
Other$22,346
Total$827,236

Hague received $363.3K in option awards, accounting for 44% of the total pay in 2018.

Hague also received $105.8K in bonus, $335.8K in salary and $22.3K in other compensation.

Rankings

In 2018, Richard Hague's compensation ranked 10,039th out of 14,244 executives tracked by ExecPay. In other words, Hague earned more than 29.5% of executives.

ClassificationRankingPercentile
All
10,039
out of 14,244
30th
Division
Manufacturing
4,050
out of 5,759
30th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
539
out of 849
37th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
331
out of 547
40th
Industry
Surgical and Medical Instruments and Apparatus
210
out of 348
40th
Source: SEC filing on April 25, 2019.

Hague's colleagues

We found five more compensation records of executives who worked with Richard Hague at Anika Therapeutics in 2018.

2018

Charles Sherwood

Anika Therapeutics

Chief Executive Officer

2018

Joseph Darling

Anika Therapeutics

Chief Executive Officer

2018

Sylvia Cheung

Anika Therapeutics

Chief Financial Officer

2018

Edward Ahn

Anika Therapeutics

Chief Technology and Strategy Officer

2018

Thomas Finnerty

Anika Therapeutics

Chief Human Resources Officer

News

You may also like